




Cite this: Org. Biomol. Chem., 2012, 10, 7062
www.rsc.org/obc PAPER
Functionalized derivatives of 1,4-dimethylnaphthalene as precursors for
biomedical applications: synthesis, structures, spectroscopy and
photochemical activation in the presence of dioxygen†
Damir Posavec,a Manfred Zabel,b Udo Bogner,c Günther Bernhardtd and Günther Knör*a
Received 28th June 2012, Accepted 17th July 2012
DOI: 10.1039/c2ob26236c
Decomposition of endoperoxide containing molecules is an attractive approach for the delayed release of
singlet oxygen under mild reaction conditions. Here we describe a new method for the adaptation of the
corresponding decay times by controlling the supramolecular functional structure of the surrounding
matrix in the immediate vicinity of embedded singlet oxygen precursors. Thus, a signiﬁcant prolongation
of the lifetime of the endoperoxide species is possible by raising the energy barrier of the thermal
1O2-releasing step via a restriction of the free volume of the applied carrier material. Enabling such a
prolonged decomposition period is crucial for potential biomedical applications of endoperoxide
containing molecules, since sufﬁcient time for appropriate cell uptake and transport to the desired target
region must be available under physiological conditions before the tissue damaging-power of the reactive
oxygen species formed is completely exhausted. Two novel polyaromatic systems for the intermediate
storage and transport of endoperoxides and the controlled release of singlet oxygen in the context of
anticancer and antibiotic activity have been prepared and characterized. These compounds are based on
functionalized derivatives of the 1,4-dimethylnaphthalene family which are readily forming metastable
endoperoxide species in the presence of dioxygen, a photosensitizer molecule such as methylene blue and
visible light. In contrast to previously known systems of similar photoreactivity, the endoperoxide
carrying molecules have been designed with optimized molecular properties in terms of potential
chemotherapeutic applications. These include modiﬁcations of polarity to improve their incorporation into
various biocompatible carrier materials, the introduction of hydrogen bonding motifs to additionally
inﬂuence the endoperoxide decay kinetics, and the synthesis of bifunctional derivatives to enable
synergistic effects of multiple singlet oxygen binding sites with an enhanced local concentration of
reactive species. With these compounds, a promising degree of endoperoxide stability adjustment within
the carrier matrix has been achieved (polymer ﬁlms or nanoparticles), which now opens the stage for
appropriate targeting of the corresponding pro-drugs into live cells. First results on cytocidal and
cytostatic properties of these compounds embedded in ethylcellulose nanoparticles are presented.
Furthermore, an efﬁcient low-cost method for the photochemical production of reactive endoperoxides
based on high-power 660 nm LED excitation at room temperature and ambient conditions in ethanol
solution is reported.
Introduction
Alkyl naphthalene derivatives such as 1,4-dimethylnaphthalene
(DMN) and related p-substituted aromatic systems are interesting
low molecular weight pro-drugs that can be photoactivated in the
presence of dioxygen, forming metastable 1,4-endoperoxides.1,2
The corresponding light-mediated O2-adducts of such systems
have been utilized for the targeted release of reactive oxygen
species such as singlet oxygen.3,4 Furthermore, the photochemi-
cal generation of oxygen-based biradical species from aromatic
endoperoxide species has also been investigated in some
detail.5,6 Important biomedical and chemotherapeutic
†Electronic supplementary information (ESI) available. CCDC 773209
(2) and 773208 (3). For ESI and crystallographic data in CIF or other
electronic format see DOI: 10.1039/c2ob26236c
aJohannes Kepler Universität Linz (JKU), Institut für Anorganische
Chemie, A-4040 Linz, Austria. E-mail: guenther.knoer@jku.at
bUniversität Regensburg, Zentrale Analytik, 93053 Regensburg,
Germany
cUniversität Regensburg, Institut für Theoretische und Physikalische
Chemie, 93053 Regensburg, Germany
dUniversität Regensburg, Institut für Pharmazie, 93053 Regensburg,
Germany

















































View Article Online / Journal Homepage / Table of Contents for this issue
applications of such systems include the delayed triggering of
singlet oxygen release, which can induce cellular damage in
malignant tissue,1 and the potential utilization of biomimetic
endoperoxide-bond cleavage processes for the controlled deacti-
vation of bacteria, viruses7 and parasites such as Plasmodium
falciparum, which is known to be responsible for the majority of
fatal malaria infections.8,9
In this context it is quite surprising that besides water solubi-
lity, relatively little attention has been paid to the optimization of
the molecular properties of such naphthalene-based carriers for
the controlled release of reactive oxygen species. To the best of
our knowledge, the only existing systematic study concentrates
on electronic and steric effects of different methylation patterns
on the reversible endoperoxide formation in a series of hydro-
phobic naphthalene derivatives.2
Here we report our ﬁrst results on the synthesis, spectroscopic
and structural characterization of two novel photoreactive DMN-
derivatives, which were functionalized in order to adjust their
solubility in media of different polarity, to enable incorporation
into various biocompatible carrier and drug delivery materials
such as liposomes or polymer nanoparticles,10 and to introduce
the possibility of synergistic interactions between multiple dioxy-
gen activation sites for the improvement of their reactivity in
terms of potential chemotherapeutic applications.
Results and discussion
Synthesis and characterization of endoperoxide compounds
The commercially available precursor DMN was used as a start-
ing material for the preparation of novel endoperoxide-forming
naphthalene derivatives according to the reaction sequence
shown in Scheme 1.
Acetylation of DMN and isolation of the 1-(1,4-dimethyl-
naphthalen-2-yl)-ethanone derivative DMNAc (1) were carried
out according to a published route.11,12 Further reduction and
condensation steps led to the in situ formation of both 1-(1,4-
dimethylnaphthalen-2-yl)-ethanol, DMNOH (2), and di-1-(1,4-
dimethylnaphthene-2-yl)-ethylether, DMNether (3), which were
separated from the reaction mixture by column chromatography.
Both DMNOH (2) and DMNether (3) derivatives were obtained
as colourless crystalline materials, which were characterized by
elemental analysis, 1H-NMR spectroscopy, mass spectroscopy,
electronic absorption and emission measurements. The crystal
structures of the two compounds are shown in Fig. 1 and 2.‡
DMNOH (2) crystallizes in the monoclinic space group P21/n,
with four molecules present in the asymmetric unit. Each
DMNOH molecule in the crystal structure forms hydrogen
bonds over the O(1)–H(1) hydroxy side-group with two other
neighbouring DMNOH molecules (not shown). The DMNether
derivative (3) crystallizes in the monoclinic space group Pbcn,
with four molecules present in the asymmetric unit.
The electronic spectra of the functionalized dimethylnaphtha-
lene derivatives were recorded in ethanol or chloroform solution.
Scheme 1
Fig. 1 X-Ray crystal structure of DMNOH (2) with an arbitrary atom
numbering scheme. Displacement ellipsoids are shown at the 50% prob-
ability level.
Fig. 2 X-Ray crystal structure of DMNether (3) with an arbitrary atom
numbering scheme. Hydrogen atoms are not included for clarity. Displa-
cement ellipsoids are shown at the 50% probability level.
‡CCDC reference numbers 773209 (2) and 773208 (3).


















































In Fig. 3, the normalized absorption and emission spectra of
DMNether (3) in CHCl3 are given as a typical example. The
UV-Vis spectra of other endoperoxide-forming naphthalene
derivatives (DMNOH, DMN) are all very similar with strong
absorption bands around 230 nm and weaker bands around
290 nm. This indicates that only negligible perturbation of the
electronic properties of the individual naphthalene chromophores
occurs in the novel ether-bridged system (3). Band maxima and
calculated molar extinction coefﬁcients for the naphthalene
derivatives (2) and (3) in ethanol are given in Table 1.
The emission spectra of the compounds investigated in this
study display a main peak at around 340 nm and two shoulders
at about 330 nm and 355 nm, respectively (Fig. 3). These data
are in agreement with the well-known features of regular ﬂuor-
escence spectra of condensed aromatic hydrocarbons, which in
the case of naphthalene derivatives usually consist of a principal
series of three to four vibronic bands equally spaced at approxi-
mately 1000 cm−1 intervals.13 In the concentration range
applied for the present study, no conspicuous band splittings or
other excited state interactions of the two equivalent
ﬂuorophore entities were detected in the bifunctional compound
DMNether (3).
When the molecules (2) or (3) in ethanol solution are irra-
diated with red light in the presence of dioxygen and methylene
blue as a photosensitizer for singlet oxygen generation, the
naphthalene-based ﬂuorescence of the DMN-derivatives gradu-
ally disappears with increasing irradiation time. This quenching
process is accompanied by the bleaching of the naphthalene
ππ*-absorption band around 290 nm due to a [4 + 2]-cyclo-
addition of singlet oxygen to the aromatic ring system forming
non-luminescent endoperoxide species (4) and (5) according to
the generally accepted reversible reaction pattern displayed in
Scheme 2.
In the dark, a gradual regeneration of the starting materials
occurs, which in analogy to other known DMN-derivatives1–3 is
thought to be coupled to a thermally induced singlet oxygen
release leading to a recovery of the initial naphthalene-based
ﬂuorescence that had been quenched by the formation of the
O2-adducts. This process can be easily studied when variations
ΔF(t) of the corresponding ﬂuorescence signal are recorded as a
function of time as shown in Fig. 4.
The decay kinetics of photogenerated endoperoxide species
(4) and (5) was measured with thermostated samples by follow-
ing the time-dependent rise of luminescence intensity monitored
at the wavelength of the ﬂuorescence band maximum of (2) and
(3). In the context of potential medical applications of the singlet
oxygen release coupled to this process, the decay of endoperox-
ides was especially traced at a human body temperature of
37 °C.
In a typical example of such an experiment, the ﬂuorescence
spectrum of a 5 μM solution of DMNether (3) in ethanol was
recorded prior to irradiation and photochemical endoperoxide
formation. After high-power LED-light exposure for 3 h at
20 °C (660 nm, 120 mW cm−2) in the presence of a sensitizer
(1 μM methylene blue), the photogenerated singlet oxygen had
efﬁciently reacted with DMNether (3) to form DMNether-endo-
peroxides (5) causing a signiﬁcant reduction of the initial ﬂuor-
escence intensity, from which the yield of this photoreaction was
calculated. It is quite important to point out that such a
Table 1 Band maxima of the electronic spectra of functionalized
DMN-derivatives at room temperature in ethanol solution
Compound λmax/nm (ε/M
−1 cm−1) λem/nm
DMNOH (2) 231 (191 000), 289 (17 200) 332, 342, 355
DMNether (3) 236 (148 000), 287 (14 600) 331, 341, 355
Fig. 3 Electronic absorption (abs) and emission (em) spectra of
DMNether (3) at room temperature in CHCl3, 1 cm cell.
Scheme 2
Fig. 4 Increasing ﬂuorescence intensity of DMNether (3) at 37 °C in
ethanol due to the gradual decomposition of photogenerated endoperox-
ides (yield 49%).


















































straightforward photo-oxidation procedure with cheap commer-
cial light sources at room temperature under ambient conditions
(air atmosphere without additional O2-saturation) is unprece-
dented and thus enables an attractive route to metastable endo-
peroxide formation in satisfactory yields without any highly
sophisticated technical equipment.
Immediately after the initial 3 h irradiation period, the ethanol
solution containing photogenerated endoperoxide species was
heated up and kept at a constant temperature (37 °C), which
caused an accelerated decay of the dioxygen adducts and regen-
erated the ﬂuorescent DMNether parent molecule (3). This
overall process and the time-dependence of the corresponding
ﬂuorescence signal was used to calculate the relative quantity of
DMNether-endoperoxide molecules (5) at each time-point in
order to determine endoperoxide decay rates and the kinetics of
1O2-release (Fig. 5).
The difference in the DMNether ﬂuorescence signal detected
at 341 nm measured before and immediately after the irradiation
period corresponds to the total number of formed endoperoxide
molecules (Fig. 4). The time-dependent reappearance of
DMNether (3) accompanied by ﬂuorescence intensity variations
ΔF(t) reﬂects the course of the thermal DMNether-endoperoxide
decay and hence provides information about the quantity of
remaining endoperoxide molecules at each time-point. ΔF(t)
reﬂects the difference in peak intensity measured before endoper-
oxide formation and for each particular curve of a certain decay
time-point and thus decreases with gradual regeneration of the
parent aromatic molecules. As shown in Fig. 5, the half-life of
DMNether-endoperoxides (5) in ethanol at 37 °C could be deter-
mined from these data as t1/2 = 2.3 h. A very similar procedure
was also carried out with the DMNOH derivative (2) in ethanol
to determine a half-life value of DMNOH-endoperoxides (4) in
ethanol at 37 °C of t1/2 = 4.4 h. The kinetic data for both com-
pounds are summarized in Table 2.
While the DMNether endoperoxide (5) decay time at 37 °C in
ethanol is shorter and comparable to the calculated decay rate of
DMN in 1,4-dioxane at the same temperature,14 the DMNOH-
endoperoxide (4) t1/2 value in ethanol is almost twice as long.
This stabilization effect is tentatively ascribed to the possibility
of a H-bonding interaction of the DMNOH-endoperoxide (4)
involving the O(1)–H(1) side-group of the DMNOH molecule
shown in Fig. 1. Further studies will however be necessary to
conﬁrm this hypothesis.15
Adaptation of decay times for delayed singlet oxygen release
With regard to the short lifespan and limited diffusion length of
singlet oxygen,16 many potential applications of metastable aro-
matic endoperoxides in pharmacy, medicine or production tech-
nology require a further prolongation of the corresponding decay
kinetics in order to reach a speciﬁc target region in due time.
Compared to processes in solution, chemical reactions involving
molecular rearrangements can be signiﬁcantly hindered in a con-
strained medium such as a polymer matrix, and the extent to
which such a process is delayed critically depends on the
remaining free volume of the system.17 Here, we introduce such
a strategy in order to achieve an adaptation of the time pro-
gression of thermally induced endoperoxide decay and singlet
oxygen formation based on a hindered molecular reorganization
process.
In Fig. 6, the structural variations which accompany 1O2-
release from a non-planar DMN-endoperoxide precursor with
two sp3-hybridized carbon centers at the oxygen binding site are
schematically illustrated.
When DMN-derivatives are embedded in different carrier
systems, the conversion between the bent endoperoxide form
and the planar aromatic system containing an intact naphthalene
moiety is strongly inﬂuenced by the properties of the encapsulat-
ing matrix material. The energetic barrier for the necessary
bending of the two DMN-subunits by an angle of Φ can be
chemically inﬂuenced by the introduction of different functional
groups, but also by the speciﬁc preparation method of the sur-
rounding polymer ﬁlm or nanoparticle carrier matrix, which
allows one to control the available free volume of the system
(Fig. 6). This latter effect may be rationally exploited to exactly
adjust the singlet oxygen delivery process to different time
scales required for a speciﬁc application. We found out that a
systematic modiﬁcation of the locally available free volume is
possible by carrying out repeated cycles of photosensitized endo-
peroxide formation and superimposed thermal decay steps in the
course of prolonged irradiation periods. With this method, an
extension of the endoperoxide decay time scale in different poly-
meric carrier materials up to a factor of 30 compared to the half-
life values obtained in organic solvents could be achieved. As an
example, the decay proﬁle of DMNOH-endoperoxide (4)
Table 2 Decay rate constants k and half-life times of photogenerated
endoperoxides at 37 °C in ethanol solution
Compound k/s−1 t1/2/h
DMNOH-endoperoxide (4) (4.41 ± 0.01) × 10−5 4.37
DMNether-endoperoxide (5) (8.53 ± 0.03) × 10−5 2.26
Fig. 5 Rise kinetics of the DMN emission spectrum in ethanol solution
at 37 °C due to thermal singlet oxygen release from photogenerated
DMNether-endoperoxides. Inset: semi-logarithmic plot of endoperoxide
content versus dark reaction time used to determine the corresponding
decay half-life times.


















































embedded in a long-term irradiated ethylcellulose (EC) nano-
particle matrix is shown in Fig. 7.
Ethylcellulose is an attractive low-cost, non-toxic matrix
material considered to be well-suitable for the microencapsula-
tion and delivery of drug molecules and other bioactive
compounds.18,19 As can be clearly seen in Fig. 7, after 24 h there
is still a signiﬁcant portion of unreacted endoperoxide groups
available for potential medical applications of EC nanoparticles
loaded with compound (4), such as cancer therapy or anti-
microbial treatments requiring a delayed release of singlet
oxygen. We therefore decided to study the time required for
uptake of such nanoparticles into live cells, and to investigate
their effects on the growth of human cancer cells as described
below (for details see ESI†).
Cellular uptake and cytotoxicity studies
To explore the potential of EC-nanoparticles as a drug-delivery
carrier system for photogenerated endoperoxides, their pene-
tration into mammalian cancer cells (MDA-MB-231) was
studied by confocal laser scanning microscopy. For this purpose,
PTC, a green ﬂuorescent perylene derivative, was employed to
demonstrate the ability of EC-nanoparticles to incorporate
organic dopant molecules. At the same time, the cellular uptake
process of the ethylcellulose particles and their localization
inside the cells could be readily followed as shown in Fig. 8.
It was found that uncoated PTC-loaded EC-nanoparticles with
an average diameter of 90 ± 20 nm only show rather slow cell
uptake. However, when the EC-particles are coated with the sur-
factant polysorbate 80TM, rapid cell penetration occurs and after
3 h the nanoparticles are dispersed in the cytoplasm of all the
cancer cells (Fig. 8). With the indication of such a reasonably
short cell-uptake time in the 1–2 h range, combined with our
novel strategy to control and adjust the delayed release of singlet
oxygen, the surfactant coated EC-nanoparticles turned out to be
Fig. 6 Microscopic model of a bent endoperoxide molecule embedded in a polymer carrier matrix. (a) Planarization of the DMN-moiety upon
singlet oxygen release; (b) matrix cavity with a large local free volume allowing rapid endoperoxide decay; (c) constrained local environment inducing
a higher barrier for the ncessary molecular rearrangements coupled to singlet oxygen formation.
Fig. 7 Semi-logarithmic plot showing a typical decay curve of
DMNOH-endoperoxide (4) embedded in ethylcellulose (EC) nanoparti-
cles (100 nm av. diameter, concentration 130 ppm w/w, prepared with a
16 h irradiation time) at 37 °C, measured by following the time-trace of
DMNOH ﬂuorescence.


















































attractive candidates for further cytotoxicity tests. Therefore, the
effects of endoperoxide loaded EC-nanoparticles on the growth
curves of human breast cancer cells (MDA-MB-231) at 37 °C
were also studied. An example of a corresponding cancer cell
proliferation diagram in the presence of control substances and
EC-nanoparticles loaded with the DMNOH-endoperoxide
derivative (4) is given in Fig. 9 (experimental details of these
assays are reported in the ESI†).
As can be seen, cancer cell incubation with the 1O2-releasing
DMNOH-endoperoxide (4) embedded in polysorbate 80™-
coated EC nanoparticles induced a very strong cytocidal effect
on the proliferation of the MDA-MB-231 cells. Non-irradiated
27 μM DMNOH (2) embedded in the same EC-nanoparticles
initially also produced approximately 40% inhibition of cell
growth, however with a signiﬁcant cell recovery starting after
125 h. This effect was most probably caused by a certain degree
of polysorbate 80™ surfactant cytotoxicity on the
MDA-MB-231 cells. For a comparison, the cytostatic effect
induced by 10 μM cisplatin dissolved in DMSO is also shown as
a benchmark. Here, the growth of the cells is about 70% inhib-
ited. It is important to note that the cell population does not
recover after treatment with 10 μM cisplatin or DMNOH-endo-
peroxide (Fig. 9). Quite similar effects on the growth of human
breast cancer cells were also observed with the DMNether based
endoperoxide (5) embedded in surfactant coated EC nanoparti-
cles. In summary, on the basis of all the results obtained with (4)
and (5), it could be concluded that after targeting the correspond-
ing carrier systems to the cells a remaining 15 μM concentration
of unreacted endoperoxide groups is required for the cytostatic
activity of these compounds.
Fig. 8 Confocal laser scanning microscopy pictures of polysorbate 80TM coated PTC-doped ethylcellulose nanoparticles (green, 100 nm av. dia-
meter) added to living MDA-MB-231 tumor cells. The progress of cell uptake is shown (a) after 1 h, and (b) after 3 h of incubation. Nuclei and mem-
branes of the cells are displayed in red.
Fig. 9 Cytocidal drug effect of 21.5 μM DMNOH-endoperoxide (4) in polysorbate 80TM coated EC-nanoparticles on the proliferation of human
breast adenocarcinoma cells (MDA-MB-231) plotted as a function of incubation time. Positive control: 10 μM cisplatin in DMSO; negative control:
H2O.




















































All chemicals were purchased in reagent grade quality and
directly used as received. Unless otherwise stated, commercially
available organic solvents of standard quality were puriﬁed and
dried according to the accepted general procedures. 1,4-
Dimethylnaphthalene (DMN, 95%) was obtained from Merck
and used as received. Ethylcellulose (EC) and cis-dichloro
diamine platinum(II) (cisplatin) were commercially available
from Sigma-Aldrich. Perylenetetracarboxylic acid (PTC) was
obtained from BASF.
1-(1,4-Dimethylnaphthalen-2-yl)-ethanone, DMNAc (1). This
was synthesized from DMN via Friedel–Crafts acetylation
according to established procedures:11,12 To a stirred solution of
anhydrous AlCl3 (13.17 g, 0.1 mol) in dichloroethane (150 mL)
was added dropwise acetyl chloride (7.1 mL, 0.1 mol) and then
also dropwise DMN (14 g, 0.09 mol). The mixture was stirred
overnight at 0–5 °C and afterwards poured into an ice-water
bath. Concentrated hydrochloric acid was added dropwise until
the brown precipitate dissolved. The organic layer was separated
and the water layer was extracted with chloroform. The com-
bined organic layers were dried over MgSO4 and concentrated.
The brown precipitate appeared from cold methanol and was
then puriﬁed by column chromatography on Al2O3 with hexane
and successive amounts of ethyl acetate as eluents to yield
8.14 g of white DMNAc (46%). During this reaction a mixture
of acetylation products, 1-(1,4-dimethylnaphthalen-2-yl)-etha-
none and 1-(1,4-dimethylnaphthalen-6-yl)-ethanone, is formed,
but only 1-(1,4-dimethylnaphthalen-2-yl)-ethanone crystallizes
from methanol. It is possible to isolate 1-(1,4-dimethylnaphtha-
len-6-yl)-ethanone by reacting the ketones with an excess of
hydroxylamine to give a mixture of oximes, treating the mixture
with concentrated HCl and then crystallizing 1-(1,4-dimethyl-
naphthalen-6-yl)-ethanone.11
DMNAc requires: 84.80% C, 7.07% H, found: 84.55% C,
7.22% H. EI-MS: m/z ratios 198.1 (DMNAc+); 183.1 (DMNAc+
− CH3); 155.1 (DMNAc+ − CH3 − CO). 1H NMR (300 MHz,
CDCl3): δ 2.60 (s, 3H), 2.65 (s, 3H), 2.71 (s, 3H), 7.35 (s, 1H),
7.55 (m, 2H), 7.97 (m, 1H), 8.14 (m, 1H).
1-(1,4-Dimethylnaphthalen-2-yl)-ethanol, DMNOH (2). To a
stirred solution of DMNAc (7.2 g, 36 mmol) in anhydrous ether
(100 mL) a suspension of LiAlH4 (1.05 g, 28 mmol) in anhy-
drous ether (100 mL) was slowly added at room temperature.
The mixture was stirred for 3 h and poured into an ice-water
bath. Hydrochloric acid was added to the contents until the white
solid was dissolved. The organic layer was separated and the
aqueous layer was extracted with ether. The combined organic
layers were dried over MgSO4 and concentrated. The crude
product was puriﬁed from DMNAc remains and from DMNether
product (see below) by column chromatography on Al2O3 using
hexane and successive amounts of ethyl acetate as eluents. Sub-
sequently, from n-hexane 1.15 g of white crystals of DMNOH
(16%) were obtained.
DMNOH requires: 84.00% C, 8.00% H, found: 83.88% C,
8.20% H. EI-MS: m/z 200.1 (DMNOH+); 185.1 (DMNOH+ −
CH3); 182.1 (DMNOH
+ − H2O).
1H NMR (300 MHz, CDCl3): δ 1.42 (d, 3H,
3JHH 6.8 Hz),
1.56 (s, 1H), 2.29 (s, 3H), 2.74 (s, 3H), 4.74 (q, 1H, 3JHH 6.8
Hz), 7.54 (m, 3H), 8.04 (m, 2H).
Di-1-(1,4-dimethylnaphthene-2-yl)-ethyl ether, DMNether
(3). The synthesis procedure was the same as for DMNOH. The
DMNether and DMNOH and DMNAc mixture was puriﬁed by
column chromatography on Al2O3 with hexane and successive
amounts of ethyl acetate as eluents. Subsequently, from dichloro-
methane 2.1 g of white crystals of DMNether (31%) were
obtained.
DMNether requires: 87.96% C, 7.85% H, found: 87.85% C,
7.58% H. EI-MS: m/z 382.3 (DMNether+); 184.2 (DMNether+ −
C14H14O).
1H NMR (300 MHz, acetone-d6): δ 1.38 (d, 6H,
3JHH 6.6 Hz),
2.29 (s, 6H), 2.73 (s, 6H), 4.76 (q, 2H, 3JHH 6.6 Hz), 7.56 (m,
6H), 8.06 (m, 4H).
Methods and instrumentation
Elemental analyses were carried out by the Centre for Chemical
Analysis of the Faculty of Natural Sciences of the University of
Regensburg. NMR spectra were recorded with a Bruker Avance
300 Spectrometer (1H: 300.1 MHz; T = 300 K). The chemical
shifts are reported in ppm relative to external standards (solvent
residual peak) and coupling constants are given in Hertz. EI-
mass spectra were obtained with a Varian CH-5 spectrometer.
Data for X-ray crystal structure determinations were collected
with an Oxford Diffraction Gemini Ultra CCD diffractometer20
with multilayer optics and Cu-Kα radiation (λ = 1.5418 Å). Elec-
tronic absorption spectra were recorded with a Varian Cary 300
Bio UV/Vis spectrophotometer and ﬂuorescence spectra were
measured with an Aminco-Bowman Series 2 Spectrometer using
Uvasol quality solvents and teﬂon stoppered 1 cm quartz cells
under aerobic conditions. Photosensitized formation of endoper-
oxides (4) and (5) was carried out in ethanol solution at 293 K
using methylene blue (MB, Sigma-Aldrich, λmax = 661 nm) as
the sensitizer. A red (λ = 660 ± 15 nm) high-power LED array of
16 power LED chips (type LED660-66-16100 from Roithner
Lasertechnik, Austria) was used as the light source. The irradi-
ance (ﬂux density) at the sample position was approximately
120 mW cm−2. Confocal laser scanning microscopy (CLSM)
and mammalian cell culture experiments with
MDA-MB-231 human breast cancer cells were carried out as
recently described in more detail.10
Conclusion
Two novel functionalized endoperoxide-forming naphthalene
derivatives DMNOH (2) and DMNether (3) of different polarity
have been described, which enable better ﬂexibility for the incor-
poration of such photoreactive derivatives in carrier materials of
various properties. The introduction of hydrogen bonding motifs
in the periphery of the compounds has been shown to inﬂuence
the endoperoxide decay kinetics. Embedding these molecules
into polymer carrier materials with a restricted free volume
around the endoperoxide site enables an adaptation of the
systems for potential medical applications requiring a signiﬁ-
cantly delayed singlet oxygen release. Furthermore, the


















































formation of bifunctional derivatives is presented as a new
concept to enable synergistic effects of multiple cooperating
singlet oxygen binding sites which could also improve their reac-
tivity as anticancer and antibiotic agents. Another general
improvement for the potential application of such endoperoxides
in the context of molecular photomedicine is the introduction of
an efﬁcient low-cost method for the visible light induced pro-
duction of reactive endoperoxides in ethanol solution based on
convenient high-power 660 nm LED excitation at room tempera-
ture under ambient conditions, thus not requiring more sophisti-
cated equipment for laser excitation or additional oxygen supply.
Successful penetration of endoperoxide loaded polymer nanopar-
ticles into human cancer cells has been studied and ﬁrst promis-
ing results on cytocidal and cytostatic effects have been
described.
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